Literature DB >> 2868530

Reducing postoperative pain, narcotics, and length of hospitalization.

G Moss, M E Regal, L Lichtig.   

Abstract

Bupivacaine wound infiltration together with efficient esophagogastric decompression and immediate elemental feeding in 43 consecutive, well-instructed patients who had undergone cholecystectomy reduced their postoperative analgesia requirements to an average of 17 (+/- 46, SD) mg of meperidine during the initial 24 hours. No analgesics were requested by 35/43 patients (81%) and 40/43 were discharged within 24 hours of surgery. All 86 conventionally treated control patients required narcotics, averaging 4.4 (+/- 0.3, SD) doses and amounting to 290 (+/- 25, SD) mg of meperidine or its equivalent during their first postoperative day and were discharged in 6.5 (+/- 0.7, SD) days. None were discharged in less than 3 days. Home interview by a visiting nurse was carried out for a block of 19 treated patients and their families. Six patients were interviewed prospectively within 33 to 64 hours of surgery, with a repeat visit 1 to 2 months later. Retrospectively studied patients were only seen 1 to 4 months after surgery. These interviews confirmed the patients' and their families' satisfaction with their bodily functions, their limited discomfort, and their independence from the hospital. Wound infiltration with a long-acting local anesthetic, efficient removal of swallowed air, and immediate, full enteral nutrition contribute to reduced postoperative pain and narcotic use in well-instructed patients, thus leading to safe and satisfactory early discharge.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2868530

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  27 in total

Review 1.  Extraperitoneal laparoscopic hernia repair with local anesthesia.

Authors:  D S Edelman; E P Misiakos; K Moses
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

2.  The use of bupivacaine to relieve pain at iliac graft donor sites.

Authors:  B D Todd; S C Reed
Journal:  Int Orthop       Date:  1991       Impact factor: 3.075

3.  Prolonged postoperative ileus-definition, risk factors, and predictors after surgery.

Authors:  Avo Artinyan; Joseph W Nunoo-Mensah; Swarna Balasubramaniam; Jim Gauderman; Rahila Essani; Claudia Gonzalez-Ruiz; Andreas M Kaiser; Robert W Beart
Journal:  World J Surg       Date:  2008-07       Impact factor: 3.352

4.  Non-invasive measurement of small-bowel motility by MRI after abdominal surgery.

Authors:  Michael A Patak; Johannes M Froehlich; Constantin von Weymarn; Stefan Breitenstein; Christoph L Zollikofer; Klaus-Ulrich Wentz
Journal:  Gut       Date:  2007-07       Impact factor: 23.059

5.  Gastrointestinal recovery following laparoscopic vs open colon surgery.

Authors:  M Hotokezaka; J Dix; E P Mentis; J S Minasi; B D Schirmer
Journal:  Surg Endosc       Date:  1996-05       Impact factor: 4.584

6.  Treatment with isoproterenol of bupivacaine toxicity.

Authors:  P Lacombe; G Blaise; F Plante; C Hollmann
Journal:  Can J Anaesth       Date:  1990-05       Impact factor: 5.063

Review 7.  Postoperative ileus.

Authors:  E H Livingston; E P Passaro
Journal:  Dig Dis Sci       Date:  1990-01       Impact factor: 3.199

8.  Secondary hyperalgesia is not affected by wound infiltration with bupivacaine.

Authors:  J M Christie; G W Chen
Journal:  Can J Anaesth       Date:  1993-11       Impact factor: 5.063

9.  The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia.

Authors:  Dawn Chung; Yoo Jin Lee; Mi Hyun Jo; Hyun Jong Park; Ga Won Lim; Hanbyoul Cho; Eun Ji Nam; Sang Wun Kim; Jae Hoon Kim; Young Tae Kim; Sunghoon Kim
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

10.  Preincisional local anesthesia with bupivacaine and pain after laparoscopic cholecystectomy. A double-blind randomized clinical trial.

Authors:  B M Ure; H Troidl; W Spangenberger; E Neugebauer; R Lefering; K Ullmann; J Bende
Journal:  Surg Endosc       Date:  1993 Nov-Dec       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.